↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "(L773:2162 4011 OR L773:2162 402X) srt2:(2015-2019) srt2:(2015)"

Search: (L773:2162 4011 OR L773:2162 402X) srt2:(2015-2019) > (2015)

Result 1-9 of 9

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Cao, Renhai, et al. (author) Editorial Material: Collaborative effects between the TNF alpha-TNFR1-macrophage axis and the VEGF-C-VEGFR3 signaling in lymphangiogenesis and metastasis in ONCOIMMUNOLOGY, vol 4, issue 3, pp 2015 In: Oncoimmunology. - : TAYLOR and FRANCIS INC. - 2162-4011 .- 2162-402X. ; 4:3, s. e989777- Journal article (other academic/artistic)abstract Although inflammation and metastasis are two well-known hallmarks of malignant disease, the relationship between inflammation and lymphatic metastasis is an unexplored research area. We recently elucidated a sophisticated mechanism by which TNF alpha-induced tumor inflammation conscripts macrophage-mediated VEGF-C-VEGFR3 signaling in lymphangiogenesis and metastasis.
2.	Ellmark, Peter, et al. (author) Kick-starting the cancer-immunity cycle by targeting CD40 2015 In: Oncoimmunology. - 2162-4011 .- 2162-402X. ; 4:7 Journal article (other academic/artistic)abstract Stimulation of CD40 on dendritic cells to expand and activate tumor-specific T cells and generate anticancer immunity is an attractive therapeutic approach. Since CD40 agonists exert their effects upstream of checkpoint inhibitors, including PD-1 or PD-L1 antagonists, they are ideal candidates for combination regimens.
3.	Apetoh, L, et al. (author) Consensus nomenclature for CD8+ T cell phenotypes in cancer 2015 In: Oncoimmunology. - 2162-4011. ; 4:4, s. e998538- Journal article (peer-reviewed)
4.	Barutello, G, et al. (author) Antitumor immunization of mothers delays tumor development in cancer-prone offspring 2015 In: Oncoimmunology. - 2162-4011. ; 4:5, s. e1005500- Journal article (peer-reviewed)
5.	Cao, RH, et al. (author) Collaborative effects between the TNFα-TNFR1-macrophage axis and the VEGF-C-VEGFR3 signaling in lymphangiogenesis and metastasis 2015 In: Oncoimmunology. - 2162-4011. ; 4:3, s. e989777- Journal article (peer-reviewed)
6.	Chevolet, I, et al. (author) Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma 2015 In: Oncoimmunology. - 2162-4011. ; 4:3, s. e982382- Journal article (peer-reviewed)
7.	Fornara, O, et al. (author) Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery 2015 In: Oncoimmunology. - 2162-4011. ; 4:9, s. e1036211- Journal article (peer-reviewed)
8.	Martner, Anna, et al. (author) Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia. 2015 In: OncoImmunology. - 2162-4011. ; 5:1, s. 1041701-1041701 Journal article (peer-reviewed)abstract In a phase IV trial, 84 patients (age 18-79) with acute myeloid leukemia (AML) in first complete remission (CR) received cycles of immunotherapy with histamine dihydrochloride (HDC) and low-dose human recombinant interleukin 2 (IL-2) for 18 months to prevent leukemic relapse. During cycles, the treatment resulted in expansion of CD56(bright) (CD3(-)/16(-)/56(bright)) and CD16(+) (CD3(-)/16(+)/56(+)) natural killer (NK) cells in the blood along with increased NK cell expression of the natural cytotoxicity receptors (NCRs) NKp30 and NKp46. Multivariate analyses correcting for age and risk group demonstrated that high CD56(bright) NK cell counts and high expression of NKp30 or NKp46 on CD16(+) NK cells independently predicted leukemia-free survival (LFS) and overall survival (OS). Our results suggest that the dynamics of NK cell subsets and their NCR expression may determine the efficiency of relapse-preventive immunotherapy in AML.
9.	Rahbar, A, et al. (author) Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV 2015 In: Oncoimmunology. - 2162-4011. ; 4:2, s. e982391- Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-9 of 9

Refine your search

Type of publication: journal article (9)

Type of content: peer-reviewed (7); other academic/artistic (2)

Author/Editor: Cavallo, F. (2); Soderberg-Naucler, C (2); Ji, H. (1); Schuler, G. (1); Ellmark, Peter (1); Bachert, C (1); show more...; Odeberg, J (1); Arigoni, M (1); Kiessling, R (1); Blay, JY (1); Castelli, C (1); Cao, YH (1); Cao, Renhai (1); Cao, Yihai (1); Yang, Yunlong (1); Zheng, YJ (1); Cao, RH (1); Wang, E. (1); Yang, YL (1); Furebring, C (1); Forni, G (1); Curcio, C (1); Anderson, Harald (1); Drake, CG (1); Holmgren, L (1); Apetoh, L (1); Smyth, MJ (1); Abastado, JP (1); Apte, RN (1); Ayyoub, M (1); Bonneville, M (1); Butterfield, LH (1); Caignard, A (1); Celis, E (1); Chen, LP (1); Colombo, MP (1); Comin-Anduix, B (1); Coukos, G (1); Dhodapkar, MV (1); Dranoff, G (1); Frazer, IH (1); Fridman, WH (1); Gabrilovich, DI (1); Gilboa, E (1); Gnjatic, S (1); Jager, D (1); Kalinski, P (1); Kaufman, HL (1); Kirkwood, J (1); Knuth, A (1); show less...

University: Karolinska Institutet (6); Lund University (2); Uppsala University (1); Linköping University (1)

Language: English (9)

Research subject (UKÄ/SCB): Medical and Health Sciences (3)

Year: 2015 (9)Undo refine

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view